These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 26979149)
1. Role of Pharmacogenomics in Kidney Disease and Injury. Awdishu L; Joy MS Adv Chronic Kidney Dis; 2016 Mar; 23(2):106-19. PubMed ID: 26979149 [TBL] [Abstract][Full Text] [Related]
2. Can we personalize treatment for kidney diseases? Rovin BH; McKinley AM; Birmingham DJ Clin J Am Soc Nephrol; 2009 Oct; 4(10):1670-6. PubMed ID: 19808246 [TBL] [Abstract][Full Text] [Related]
3. Assessment of drug metabolism enzyme and transporter pharmacogenetics in drug discovery and early development: perspectives of the I-PWG. Brian W; Tremaine LM; Arefayene M; de Kanter R; Evers R; Guo Y; Kalabus J; Lin W; Loi CM; Xiao G Pharmacogenomics; 2016 Apr; 17(6):615-31. PubMed ID: 27045656 [TBL] [Abstract][Full Text] [Related]
4. Individualization of immunosuppression: concepts and rationale. Wavamunno MD; Chapman JR Curr Opin Organ Transplant; 2008 Dec; 13(6):604-8. PubMed ID: 19060550 [TBL] [Abstract][Full Text] [Related]
5. New challenges and promises in solid organ transplantation pharmacogenetics: the genetic variability of proteins involved in the pharmacodynamics of immunosuppressive drugs. Pouché L; Stojanova J; Marquet P; Picard N Pharmacogenomics; 2016 Feb; 17(3):277-96. PubMed ID: 26799749 [TBL] [Abstract][Full Text] [Related]
6. [Immunotherapy mechanisms in glomerulonephritis]. Polci R; Feriozzi S G Ital Nefrol; 2011; 28(6):612-21. PubMed ID: 22167612 [TBL] [Abstract][Full Text] [Related]
7. Cancer pharmacogenomics: achievements in basic research. Nakajima M; Yokoi T Int J Clin Oncol; 2005 Feb; 10(1):14-9. PubMed ID: 15729595 [TBL] [Abstract][Full Text] [Related]
8. Role of pharmacogenetics of immunosuppressive drugs in organ transplantation. Thervet E; Anglicheau D; Legendre C; Beaune P Ther Drug Monit; 2008 Apr; 30(2):143-50. PubMed ID: 18367973 [TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics and the concept of individualized medicine. Shastry BS Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022 [TBL] [Abstract][Full Text] [Related]
10. [Pharmacogenetics/pharmacogenomics in psychiatry]. Ueda M; Ishiguro S; Watanabe T; Saeki Y; Shimoda K Nihon Rinsho; 2010 Jan; 68(1):155-62. PubMed ID: 20077810 [TBL] [Abstract][Full Text] [Related]
11. [Clinical relevance of drug metabolism polymorphisms]. Mikus G Ther Umsch; 2000 Sep; 57(9):573-8. PubMed ID: 11036438 [TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil for lupus nephritis: an update. Mok CC Expert Rev Clin Immunol; 2015; 11(12):1353-64. PubMed ID: 26364748 [TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects. Sim SC; Kacevska M; Ingelman-Sundberg M Pharmacogenomics J; 2013 Feb; 13(1):1-11. PubMed ID: 23089672 [TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics and pharmacogenomics in rheumatology. Szekanecz Z; Meskó B; Poliska S; Váncsa A; Szamosi S; Végh E; Simkovics E; Laki J; Kurkó J; Besenyei T; Mikecz K; Glant TT; Nagy L Immunol Res; 2013 Jul; 56(2-3):325-33. PubMed ID: 23564183 [TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research. Arranz MJ; de Leon J Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063 [TBL] [Abstract][Full Text] [Related]
16. Calcineurin inhibitors and hypertension: a role for pharmacogenetics? Moes AD; Hesselink DA; Zietse R; van Schaik RH; van Gelder T; Hoorn EJ Pharmacogenomics; 2014 Jun; 15(9):1243-51. PubMed ID: 25141899 [TBL] [Abstract][Full Text] [Related]
17. [State of the art of pharmacogenetic diagnostics in drug therapy]. Kirchheiner J; Seeringer A; Brockmöller J Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):995-1003. PubMed ID: 17013776 [TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics of drug metabolising enzymes: importance for personalised medicine. Oscarson M Clin Chem Lab Med; 2003 Apr; 41(4):573-80. PubMed ID: 12747605 [TBL] [Abstract][Full Text] [Related]
19. Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes. Kirchheiner J; Seeringer A Biochim Biophys Acta; 2007 Mar; 1770(3):489-94. PubMed ID: 17113714 [TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics and pharmacogenetics for the intensive care unit: a narrative review. MacKenzie M; Hall R Can J Anaesth; 2017 Jan; 64(1):45-64. PubMed ID: 27752976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]